FDA Inspection 1331920 — Natco Pharma Limited
The FDA completed an inspection of Natco Pharma Limited on Aug 21, 2026 in Anakapalli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Anakapalli (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 1222 | 21 CFR 211.67(b)(4) | Cleaning SOPs/equipment identification |
| 1274 | 21 CFR 211.68(a) | Calibration/Inspection/Checking not done |
| 1842 | 21 CFR 211.84(d)(1) | Component identity verification |
| 3547 | 21 CFR 211.46(b) | Equipment for Environmental Control |